Adherence to combined Lamivudine+Zidovudine versus individual components: A community-based retrospective medicaid claims analysis

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 17, Issue 8, 2005, Pages 938-948

  Legorreta, A ^a,c   Yu, A ^b   Chernicoff, H ^c   Gilmore, A ^c   Jordan, J ^d   Rosenzweig, J C ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Health Benchmarks Inc   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT FAILURE;

ADULT; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LAMIVUDINE; MALE; MEDICAID; MIDDLE AGED; PATIENT COMPLIANCE; ZIDOVUDINE;

EID: 27144468361     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120500100692     Document Type: Article

References (38)

1. Andrews, L., & Friedland, G. (2000). Progress in HIV therapeutics and the challenges of adherence to antiretroviral therapy. Infectious Disease Clinics of North America., 14, 901-928.
2. Arnsten, J., Demas, P., Farzadegan, H., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417-23.
3. Bangsberg, D. R., Hecht, F. M., Clague, H., et al. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435-42.
4. Bartlett, J. A., DeMasi, R., Quinn, J., Moxham, C., & Rousseau, F. (2001). Overview of the effectiveness of triple combination therapy in antiretroviral-naïve HIV-1 infected adults. AIDS, 15, 1369-77.
5. th World AIDS Conference. Geneva, June [Abstract #60356].
6. Carpenter, C., Cooper, D., Fischl, M., et al. (2001). Antiretroviral therapy in adults - Updated Recommendations of the International AIDS Society - USA Panel. JAMA, 283(3), 381-90.
7. Chesney, M. A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 50(Suppl 2), S171-6.
8. Cremieux, A. C., Katlama, C., Gillotin, C., et al. (2001). A comparison of steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and abacavir plus lamivudine-zidovudine double combination tablet by HIV-1 infected adults. Pharmacotherapy, 21 (4), 424-30.
9. Jordan, J., Delea, T., Sherrill, B., et al. Impact of a fixed-dose combination zidovudine/lamivudine on adherence to anti-retroviral therapy: a retrospective claims-based cohort study. Sixth International Congress on Drug Therapy in HIV Infection, 17-21 November 2002, Glasgow. Poster 97.
10. Egger, M., Hirschel, B., Francioli, P., et al. (1997). Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. British Medical Journal, 315, 1194-9.
11. Erb, P., Battegay, M., Zimmerli, W., Rickenbach, M., & Egger, M. (2000). Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study. Archives of Internal Medicine, 160, 1134-40.
12. Eron, J. J., Yetzer, E.S., Ruane, P. J., et al. (2000). Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine table formulation, plus a protease inhibitor, in HIV infection. AIDS, 14(6), 671-81.
13. Parley, J., Hines, S., Musk, A., Ferrus, S., & Tepper, V. (2003). Assessment of adherence to antiretroviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. Journal of Acquired Immune Deficiency Syndromes, 33, 211-8.
14. Golin, C. E., Liu, H., Hays, R., et al. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756-65.
15. th World AIDS Conference. Geneva, June.
16. Hill, Z., Kendall, C., & Fernandez, M. (2003). Patterns of adherence to antiretrovirals: Why adherence has no simple measure. AIDS Patient Care and STDs, 17(10), 519-25.
17. Hogg, R., Heath, K., Yip, B., et al. (1998). Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA, 279(6), 450-4.
18. Hogg, R., Heath, K., Bangsberg, D., et al. (2002). Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS, 16, 1051-8.
19. Jacobson, L. P., Li, R., Phair, J., et al. (2002). Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression. American Journal of Epidemiology, 155(8), 760-70.
20. Jordan, R., Gold, L., Cummins, C., & Hyde, C. (2002). Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy. British Medical Journal, 324, 1-10.
21. Knobel, H., Carmona, A., Grau, S., et al. (1998). Adherence and effectiveness of highly active antiretroviral therapy. Archives of Internal Medicine, 158, 1953.
22. Laine, C., Newschaffer, C., Zhang, D., Cosler, L., Hauck, W., & Turner, B. (2000). Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: A pharmacy claims-based analysis. Obstetrics and Gynecology, 95, 167-73.
23. Long, S. (1997). Regression models for categorical and limited dependent variables. Thousand Oaks: Sage Publications.
24. McNabb, J. J., Nicolau, D. P., Stoner, J.A., & Ross, J. (2003). Patterns of adherence to antiretroviral medications: the value of electronic monitoring. AIDS, 17, 1763-7.
25. Mooney C., & Duval R. 1993 Bootstrapping: A nonparametric approach to statistical inference. Volume 95 in Quantitative Applications in the Social Sciences. Newbury Park, CA: Sage Publications Inc.
26. Moore, K. H., Shaw, S., Laurent, A. L., et al. (1999). Lamivudine/zidovudine as a combined formulation tablet: Bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption. Journal of Clinical Pharmacology, 39(6), 593-605.
27. Nieuwkerk, P., Sprangers, M., Burger, D., et al. (2001). Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Archives of Internal Medicine, 161, 1962-8.
28. Ostrop, N., Hallett, K., & Gill, M. J. (2000). Long-term patient adherence to antiretroviral therapy. Annals of Pharmacotherapy, 34(6), 703-9.
29. Palella, F. J., Delaney, K.M., Moorman, A. C., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. The New England Journal of Medicine, 338(13), 853-60.
30. Parpia, T., Raab, G.M., Goldberg, D. J., et al. (2001). Effect of combination therapy on immunologic progression of human immunodeficiency virus at a population level. American Journal of Epidemiology, 153, 898-902.
31. Paterson, D. L., Swindells, S., Mohr, J., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
32. Prentice, R. L., Williams, B. J., & Peterson, A. V. (1981). On the regression analysis of multivariate failure time data. Biometrika, 68, 373-9.
33. Remien, R. H., Hirky, A. E., Johnson, M. O., et al. (2003). Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four U.S. cities. AIDS and Behavior, 7(1), 61-72.
34. Stone, V. E., Hogan, J. W., Schuman, P., et al. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the HER study. Journal Of Acquired Immune Deficiency Syndromes, 28, 124-31.
35. Stone, V. E., Clarke, J., Lovell, J., et al. (1998). HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors. Journal of General Internal Medicine, 13, 586-93.
36. Turner, B. J., Newschaffer, C. J., Zhang, D., Cosler, L., & Walter, H. (2000). Antiretroviral therapy and pharmacy-based measurement of adherence in postpartum HIV-infected women. Medical Care, 38(9), 911 -25.
37. Turner, B. (2002). Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. The Journal of Infectious Diseases, 185(Suppl 2), S143-51.
38. Walkup, J., Sambamoorthi, U., & Crystal, S. (2004). Use of newer antiretroviral treatments among HIV-infected Medicaid beneficiaries with serious mental illness. Journal of Clinical Psychiatry, 65, 1180-89.